 |
Caribou Biosciences
Last updated: July 31, 2024
Rachel E. Haurwitz, Co-founder
USA | Funding: $317.7M (+)
Website: http://cariboubio.com/
Caribou Biosciences is a pioneer in the revolutionary field of CRISPR-Cas genome editing. Our proprietary technology puts us at the forefront of the development of new medical therapies and bio-based products which offer profound benefits to both human health and society as a whole.
Website: http://cariboubio.com/
Caribou Biosciences is a pioneer in the revolutionary field of CRISPR-Cas genome editing. Our proprietary technology puts us at the forefront of the development of new medical therapies and bio-based products which offer profound benefits to both human health and society as a whole.
